Literature DB >> 31896812

Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update.

Sofia Garces1,2, C Cameron Yin1, Roberto N Miranda1, Keyur P Patel1, Shaoying Li1, Jie Xu1, Beenu Thakral1, Robert J Poppiti2, Ana Maria Medina2, Vathany Sriganeshan2, Amilcar Castellano-Sánchez2, Joseph D Khoury1, Juan Carlos Garces3, L Jeffrey Medeiros4.   

Abstract

Dermatopathic lymphadenopathy is a distinctive form of paracortical lymph node hyperplasia that usually occurs in the setting of chronic dermatologic disorders. The aim of this study is to update our understanding of the clinicopathologic and immunophenotypic features of dermatopathic lymphadenopathy. The study cohort was 50 lymph node samples from 42 patients diagnosed with dermatopathic lymphadenopathy. The patients included 29 women and 13 men with a median age of 49 years (range, 12-79). Twenty-two (52%) patients had a dermatologic disorder, including mycosis fungoides (n = 6), chronic inflammatory dermatoses (n = 13), melanoma (n = 1), squamous cell carcinoma (n = 1), and Kaposi sarcoma in the context of human immunodeficiency virus infection (n = 1). Twenty (48%) patients did not have dermatologic manifestations. Lymph node biopsy specimens were axillary (n = 22), inguinal (n = 21), cervical (n = 4), and intramammary (n = 3). All lymph nodes showed paracortical areas expanded by lymphocytes; dendritic cells, including interdigitating dendritic cells and Langerhans cells; and macrophages. Melanophages were detected in 48 (98%) lymph nodes. Immunohistochemical analysis provided results that are somewhat different from those previously reported in the literature. In the paracortical areas of lymph node, S100 protein was expressed in virtually all dendritic cells, and CD1a was expressed in a significantly greater percentage of cells than langerin (80 vs. 35%, p < 0.0001). These results suggest that the paracortical regions of dermatopathic lymphadenopathy harbor at least three immunophenotypic subsets of dendritic cells: Langerhans cells (S100+, CD1a+(high), langerin+), interdigitating dendritic cells (S100+, CD1a+(low), langerin-), and a third (S100+, CD1a-, langerin-) minor population of dendritic cells. Furthermore, in more than 60% of dermatopathic lymph nodes, langerin highlighted trabecular and medullary sinuses and cords, showing a linear and reticular staining pattern, which could be a pitfall in the differential diagnosis with Langerhans cell histiocytosis involving lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31896812     DOI: 10.1038/s41379-019-0440-4

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  51 in total

1.  Langerhans cells and interdigitating reticulum cells in the thymus-dependent region in human dermatopathic lymphadenitis.

Authors:  E Rausch; E Kaiserling; M Goos
Journal:  Virchows Arch B Cell Pathol       Date:  1977-11-21

2.  Frédéric Woringer: Pautrier-Woringer disease (lipomelanotic reticulosis/dermatopathic lymphadenitis).

Authors:  Charles Steffen
Journal:  Am J Dermatopathol       Date:  2004-12       Impact factor: 1.533

3.  Distinctive localization of antigen-presenting cells in human lymph nodes.

Authors:  Catherine E Angel; Chun-Jen J Chen; Oliver C Horlacher; Sintia Winkler; Thomas John; Judy Browning; Duncan MacGregor; Jonathan Cebon; P Rod Dunbar
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

4.  Cells containing Langerhans granules in human lymph nodes of dermatopathic lymphadenopathy.

Authors:  K Jimbow; S Sato; A Kukita
Journal:  J Invest Dermatol       Date:  1969-10       Impact factor: 8.551

5.  Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells.

Authors:  H Hemmi; M Yoshino; H Yamazaki; M Naito; T Iyoda; Y Omatsu; S Shimoyama; J J Letterio; T Nakabayashi; H Tagaya; T Yamane; M Ogawa; S Nishikawa; K Ryoke; K Inaba; S Hayashi; T Kunisada
Journal:  Int Immunol       Date:  2001-05       Impact factor: 4.823

6.  Immuno-histochemical characterisation of cells involved in dermatopathic lymphadenopathy.

Authors:  I A Lampert; G Pizzolo; A Thomas; G Janossy
Journal:  J Pathol       Date:  1980-06       Impact factor: 7.996

7.  Characterization of resident and migratory dendritic cells in human lymph nodes.

Authors:  Elodie Segura; Jenny Valladeau-Guilemond; Marie-Hélène Donnadieu; Xavier Sastre-Garau; Vassili Soumelis; Sebastian Amigorena
Journal:  J Exp Med       Date:  2012-03-19       Impact factor: 14.307

Review 8.  Human dendritic cell subsets.

Authors:  Matthew Collin; Naomi McGovern; Muzlifah Haniffa
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 9.  Human dendritic cell subsets: an update.

Authors:  Matthew Collin; Venetia Bigley
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

10.  Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin.

Authors:  F Geissmann; M C Dieu-Nosjean; C Dezutter; J Valladeau; S Kayal; M Leborgne; N Brousse; S Saeland; J Davoust
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  3 in total

1.  Multimodal imaging findings including high-resolution 3D T2-weighted imaging for COVID-19 vaccine-associated axillary lymphadenopathy in a patient with breast cancer.

Authors:  Hiroaki Shimizu; Naoko Mori; Hainan Ren; Minoru Miyashita; Satoko Sato; Shunji Mugikura; Kei Takase
Journal:  Radiol Case Rep       Date:  2022-06-10

2.  A case of dermatopathic lymphadenitis mimicking lymphoma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.

Authors:  Koon Kiu Ng; Yan Ho Hui; Boom Ting Kung; Ting Kun Au Yong
Journal:  World J Nucl Med       Date:  2020-09-14

Review 3.  Adult-onset Still's disease with multiple lymphadenopathy: a case report and literature review.

Authors:  Zhonghua Huang; Hua Xu; Qinqin Min; Zhenguo Li; Jiaxin Bi; Lingyun Liu; Yingying Liang
Journal:  Diagn Pathol       Date:  2021-10-27       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.